Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 2353-2357

  Vuorte, Juha ^a   Lindsberg, Perttu J ^b   Kaste, Markku ^b   Meri, Seppo ^a   Jansson, Sten Erik ^b,c   Rothlein, Robert ^d   Repo, Heikki ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENYLOXAZOLONE; BIRR 1; CD11B ANTIGEN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; L SELECTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY R6.5; OXAZOLONE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPLEMENT ACTIVATION; COMPLEMENT FIXATION; CONTROLLED STUDY; EXTRAVASATION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INFLAMMATORY DISEASE; KIDNEY ALLOGRAFT; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; RESPIRATORY BURST; RHEUMATOID ARTHRITIS; TISSUE INJURY; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, MONOCLONAL; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; HUMANS; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE-1; MICE; MUROMONAB-CD3; NEUTROPHIL ACTIVATION; RECEPTORS, COMPLEMENT 3B;

EID: 0033557749     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Lawrence, M. B., and T. A. Springer. 1991. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65:859.
2. McEver, R. P., K. L. Moore, and R. D. Cummings. 1995. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J. Biol. Chem. 270:11025.
3. Rosen, H., and S. Gordon. 1987. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med. 166:1685.
4. 2-integrins and their cellular ligands. Eur. J. Biochem. 245:215.
5. Lorant, D. E., M. K. Topham, R. E. Whatley, R. P. McEver, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1993. Inflammatory roles of P-selectin. J. Clin. Invest. 92:559.
6. Lloyd, A. R., J. J. Oppenheim, K. J. Kelvin, and D. D. Taub. 1996. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J. Immunol. 156: 932.
7. Schall, T. J., and K. B. Bacon. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6:865.
8. Berger, M., J. O'Shea, A. S. Cross, T. M. Folks, T. M. Chused, E. J. Brown, and M. M. Frank. 1984. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J. Clin. Invest. 74:1566.
9. Kishimoto, T. K., M. A. Jutila, E. L. Berg, and E. C. Butcher. 1989. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245:1238.
10. Hill, M. A., I. N. Bird, R. H. Daniels, M. A. Elmore, and M. J. Finnen. 1994. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1β-treated endothelial monolayers. J. Immunol. 153:3673.
11. Diamond, M. S., and T. A. Springer. 1993. A subpopulation of Mac-1 (CD11b/ CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell. Biol. 120:545.
12. Staunton, D. E., S. D. Marlin, C. Stratowa, M. L. Dustin, and T. A. Springer. 1988. Primary structure of intercellular adhesion molecule 1 (ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52:925.
13. Simmons, D., M. W. Makgoba, and B. Seed. 1988. ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 331:624.
14. Dustin, M. L., R. Rothlein, A. K. Bhan, C. A. Dinarello, and T. A. Springer. 1986. Induction by IL-1 and IFN-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:245.
15. Munro, J. M., J. S. Pober, and R. S. Cotran. 1989. Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Pabio anubis. Am. J. Pathol. 135:121.
16. Smith, C. W., R. Rothlein, B. J. Hughes, M. M. Mariscalco, H. E. Rudloff, F. C. Schmalstieg, and D. C. Anderson. 1988. Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelial migration. J. Clin. Invest. 82:1746.
17. Barton, R. W., R. Rothlein, J. Ksiazek, and C. Kennedy. 1989. The effect of anti-ICAM-1 on phorbol-ester-induced rabbit lung inflammation. J. Immunol. 143:1278.
18. Dougherty, G. J., S. Murdoch, and N. Hogg. 1988. The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J. Immunol. 18:35.
19. Sligh, J. E., Jr., C. M. Ballantyne, S. S. Rich, H. K. Hawkins, C. W. Smith, A. Bradley, and A. L. Beaudet. 1993. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl Acad. Sci. USA 90:8529.
20. Cosimi, A. B., D. Conti, F. L. Delmonico, F. I. Preffer, S. L. Wee, R. Rothlein, R. Faanes, and R. B. Colvin. 1990. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J. Immunol. 144: 4604.
21. Argenbright, L. W., L. G. Letts, and R. Rothlein. 1991. Monoclonal antibodies to the leukocyte membrane CD18 glycoprotein complex and to intercellular adhesion molecule-1 inhibit leukocyte-endothelial adhesion in rabbits. J. Leukocyte Biol. 49:253.
22. Wee, S. L., A. B. Cosimi, F. I. Preffer, R. Rothlein, R. Faanes, D. Conti, and R. B. Colvin. 1991. Functional consequences of anti-ICAM-1 (CD54) in cynomolgus monkeys with renal allografts. Transplant. Proc. 23:279.
23. Bowes, M. P., R. Rothlein, S. C. Fagan, and J. A. Zivin. 1995. Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 45:815.
24. Kavanaugh, A. F., L. S. Davis, L. A. Nichols, S. H. Norris, R. Rothlein, L. A. Scharschmidt, and P. E. Lipsky. 1994. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 37:992.
25. Rothlein, R., T. K. Kishimoto, and E. Mainolfi. 1994. Cross-linking of ICAM-1 induces cosignaling of an oxidative burst from mononuclear leukocytes. J. Immunol. 152:2488.
26. Haug, C. E., R. B. Colvin, F. L. Delmonico, H. Auchincloss, Jr., N. Tolkoff-Rubin, F. I. Preffer, R. Rothlein, S. Norris, L. Scharschmidt, and A. B. Cosimi. 1993. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766.
27. Bass, D. A., W. Parce, L. R. Dechatelet, P. Szejda, M. C. Seeds, and M. Thomas. 1983. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130:1910.
28. Vuorte, J., S.-E. Jansson, and H. Repo. 1996. Standardization of a flow cytometric assay for phagocyte respiratory burst activity. Scand. J. Immunol. 43:329.
29. Repo, H., S.-E. Jansson, and M. Leirisalo-Repo. 1993. Flow cytometric determination of CD11b upregulation in vivo. J. Immunol. Methods 164:193.
30. Repo, H., S.-E. Jansson, and M. Leirisalo-Repo. 1995. Anticoagulant selection influences flow cytometric determination of CD11b upregulation in vivo and ex vivo. J. Immunol. Methods 185:65.
31. Repo, H., Y. P. Rochon, B. R. Schwartz, S. R. Sharar, R. K. Winn, and J. M. Harlan. 1997. Binding of human peripheral blood polymorphonuclear leukocytes to E-selectin (CD62E) does not promote their activation. J. Immunol. 159:943.
32. Weisman, H. F., T. Bartow, M. K. Leppo, H. C. Marsh, G. R. Carson, M. F. Concino, M. P. Boyle, K. H. Roux, M. L. Weisfeldt, and D. T. Fearon. 1990. Soluble human complement receptor type I: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146.
33. Raasveld, M. H. M., F. J. Bemelman, P. T. A. Schellekens, F. N. van Diepen, A. van Dongen, E. A. van Royen, C. E. van Hack, and I. J. ten Berge. 1993. Complement activation during OKT3 treatment: a possible explanation for respiratory side effects. Kidney Int. 43:1140.
34. Schmaldienst, S., G. Bohmig, E. Pohanka, J. Kovarik, and G. J. Zlabinger. 1992. Evidence for granulocyte activation by OKT3. Transplant. Proc. 24:2600.
35. Brüggemann, M., G. T. Williams, C. I. Bindon, M. R. Clark, M. R. Walker, R. Jefferis, H. Waldmann, and M. S. Neuberger. 1987. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J. Exp. Med. 166:1351.
36. Arnaout, M. A., R. M. Hakim, R. F. Todd, III, N. Dana, and H. R. Colten. 1985. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N. Engl. J. Med. 312:457.
37. Buyon, J. P., N. Shadick, R. Berkman, P. Hopkins, J. Dalton, G. Weissman, R. Winchester, and S. B. Abramson. 1988. Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus. Clin. Immunol. Immunopathol. 46:141.
38. Lin, R. Y., M. E. Astiz, J. C. Saxon, and E. C. Rackow. 1993. Altered leukocyte immunophenotypes in septic shock. Chest 104:847.
39. Rosenbloom, A. J., M. R. Pinsky, J. L. Bryant, A. Shin, T. Tran, and T. Whiteside. 1995. Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. J. Am. Med. Assoc. 274:58.
40. Emmrich, F., G. Horneff, W. Becker, W. Luke, A. Potocnik, U. Kanzy, J. R. Kalden, and G. Burmester. 1991. An anti-CD4 antibody for treatment of chronic inflammatory arthritis. Agents Actions Suppl. 32:165.
41. Goldberg, D., P. Morel, L. Chatenoud, C. Boitard, C. J. Menkes, P. H. Bertoye, J. P. Revillard, and J. F. Bach. 1991. Immunological effects of high-dose administration of anti-CD4 antibody in rheumatoid arthritis patients. J. Autoimmun. 4:617.
42. Reiter, C., B. Kakavand, E. P. Rieber, M. Schattenkirchner, G. Riethmüller, and K. Krüger. 1991. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Arthritis Rheum. 34:525.
43. Sherman, D. G. 1997. The Enlimomab Acute Stroke Trial: final results. Neurology 4H:A270 (Abstr.). Data also presented at the 49th Annual Meeting of the American Academy of Neurology, 1997, Boston, MA.
44. Lindsberg, P. J., O. Carpén, A. Paetau, M.-L. Karjalainen-Lindsberg, and M. Kaste. 1996. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 94:939.